Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Long live the king: chromosome-level assembly of the lion (Panthera leo) using linked-read, Hi-C, and long-read data.

Armstrong EE, Taylor RW, Miller DE, Kaelin CB, Barsh GS, Hadly EA, Petrov D.

BMC Biol. 2020 Jan 8;18(1):3. doi: 10.1186/s12915-019-0734-5.

2.

Collaborative response to arsenic-contaminated soil in an Appalachian Kentucky neighborhood.

Yaffee AQ, Scott B, Kaelin C, Cambron J, Sanderson W, Christian WJ, Moran TP, Chamness J.

J Toxicol Environ Health A. 2019;82(12):697-701. doi: 10.1080/15287394.2019.1641872. Epub 2019 Jul 15.

PMID:
31307340
3.

Health Care Utilization and Mental Health Diagnoses Among Veterans With Tinnitus.

Carlson KF, Gilbert TA, O'Neil ME, Zaugg TL, Manning CA, Kaelin C, Thielman EJ, Reavis KM, Henry JA.

Am J Audiol. 2019 Apr 22;28(1S):181-190. doi: 10.1044/2018_AJA-TTR17-18-0042.

PMID:
31022360
4.

Telephone-Based Progressive Tinnitus Management for Persons With and Without Traumatic Brain Injury: A Randomized Controlled Trial.

Henry JA, Thielman EJ, Zaugg TL, Kaelin C, McMillan GP, Schmidt CJ, Myers PJ, Carlson KF.

Ear Hear. 2019 Mar/Apr;40(2):227-242. doi: 10.1097/AUD.0000000000000609.

PMID:
29847413
5.

Development and field testing of a smartphone "App" for tinnitus management.

Henry JA, Thielman E, Zaugg T, Kaelin C, Choma C, Chang B, Hahn S, Fuller B.

Int J Audiol. 2017 Oct;56(10):784-792. doi: 10.1080/14992027.2017.1338762. Epub 2017 Jul 2.

PMID:
28669224
6.

Need for Mental Health Providers in Progressive Tinnitus Management: A Gap in Clinical Care.

Schmidt CJ, Kaelin C, Henselman L, Henry JA.

Fed Pract. 2017 May;34(5):6-9. No abstract available.

7.

Randomized Controlled Trial in Clinical Settings to Evaluate Effectiveness of Coping Skills Education Used With Progressive Tinnitus Management.

Henry JA, Thielman EJ, Zaugg TL, Kaelin C, Schmidt CJ, Griest S, McMillan GP, Myers P, Rivera I, Baldwin R, Carlson K.

J Speech Lang Hear Res. 2017 May 24;60(5):1378-1397. doi: 10.1044/2016_JSLHR-H-16-0126.

PMID:
28418492
8.

Multisite Randomized Controlled Trial to Compare Two Methods of Tinnitus Intervention to Two Control Conditions.

Henry JA, Stewart BJ, Griest S, Kaelin C, Zaugg TL, Carlson K.

Ear Hear. 2016 Nov/Dec;37(6):e346-e359.

PMID:
27438870
9.

Electrostatic Similarity Analysis of Human β-Defensin Binding in the Melanocortin System.

Nix MA, Kaelin CB, Palomino R, Miller JL, Barsh GS, Millhauser GL.

Biophys J. 2015 Nov 3;109(9):1946-58. doi: 10.1016/j.bpj.2015.09.005. Erratum in: Biophys J. 2015 Dec 15;109(12):2701. Biophys J. 2015 Dec 15;109(12):2701.

10.

Tinnitus Functional Index: Development, validation, outcomes research, and clinical application.

Henry JA, Griest S, Thielman E, McMillan G, Kaelin C, Carlson KF.

Hear Res. 2016 Apr;334:58-64. doi: 10.1016/j.heares.2015.06.004. Epub 2015 Jun 12.

PMID:
26074306
11.

Tinnitus and hearing survey: a screening tool to differentiate bothersome tinnitus from hearing difficulties.

Henry JA, Griest S, Zaugg TL, Thielman E, Kaelin C, Galvez G, Carlson KF.

Am J Audiol. 2015 Mar;24(1):66-77. doi: 10.1044/2014_AJA-14-0042.

12.

Development of a progressive audiologic tinnitus management program for Veterans with tinnitus.

Myers PJ, Griest S, Kaelin C, Legro MW, Schmidt CJ, Zaugg TL, Henry JA.

J Rehabil Res Dev. 2014;51(4):609-22. doi: 10.1682/JRRD.2013.08.0189.

13.

Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein.

Warne JP, Varonin JM, Nielsen SS, Olofsson LE, Kaelin CB, Chua S Jr, Barsh GS, Koliwad SK, Xu AW.

J Neurosci. 2013 Jul 17;33(29):11972-85. doi: 10.1523/JNEUROSCI.0830-13.2013. Retraction in: J Neurosci. 2014 Oct 8;34(41):13865.

14.

Molecular and functional analysis of human β-defensin 3 action at melanocortin receptors.

Nix MA, Kaelin CB, Ta T, Weis A, Morton GJ, Barsh GS, Millhauser GL.

Chem Biol. 2013 Jun 20;20(6):784-95. doi: 10.1016/j.chembiol.2013.04.015.

15.

Pilot study to develop telehealth tinnitus management for persons with and without traumatic brain injury.

Henry JA, Zaugg TL, Myers PJ, Schmidt CJ, Griest S, Legro MW, Kaelin C, Thielman EJ, Storzbach DM, McMillan GP, Carlson KF.

J Rehabil Res Dev. 2012;49(7):1025-42.

16.

Genetics of pigmentation in dogs and cats.

Kaelin CB, Barsh GS.

Annu Rev Anim Biosci. 2013 Jan;1:125-56. doi: 10.1146/annurev-animal-031412-103659. Epub 2013 Jan 3. Review.

PMID:
25387014
17.

Specifying and sustaining pigmentation patterns in domestic and wild cats.

Kaelin CB, Xu X, Hong LZ, David VA, McGowan KA, Schmidt-Küntzel A, Roelke ME, Pino J, Pontius J, Cooper GM, Manuel H, Swanson WF, Marker L, Harper CK, van Dyk A, Yue B, Mullikin JC, Warren WC, Eizirik E, Kos L, O'Brien SJ, Barsh GS, Menotti-Raymond M.

Science. 2012 Sep 21;337(6101):1536-41.

18.

Loop-swapped chimeras of the agouti-related protein and the agouti signaling protein identify contacts required for melanocortin 1 receptor selectivity and antagonism.

Patel MP, Cribb Fabersunne CS, Yang YK, Kaelin CB, Barsh GS, Millhauser GL.

J Mol Biol. 2010 Nov 19;404(1):45-55. doi: 10.1016/j.jmb.2010.08.054. Epub 2010 Sep 8.

19.

Tabby pattern genetics - a whole new breed of cat.

Kaelin C, Barsh G.

Pigment Cell Melanoma Res. 2010 Aug;23(4):514-6. doi: 10.1111/j.1755-148X.2010.00723.x. Epub 2010 May 26. No abstract available.

PMID:
20518859
20.

Genetics of Sex-linked yellow in the Syrian hamster.

Alizadeh A, Hong LZ, Kaelin CB, Raudsepp T, Manuel H, Barsh GS.

Genetics. 2009 Apr;181(4):1427-36. doi: 10.1534/genetics.108.095018. Epub 2009 Feb 2.

21.

New ligands for melanocortin receptors.

Kaelin CB, Candille SI, Yu B, Jackson P, Thompson DA, Nix MA, Binkley J, Millhauser GL, Barsh GS.

Int J Obes (Lond). 2008 Dec;32 Suppl 7:S19-27. doi: 10.1038/ijo.2008.234. Review.

PMID:
19136986
22.

Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy.

Patenaude AF, Orozco S, Li X, Kaelin CM, Gadd M, Matory Y, Mayzel K, Roche CA, Smith BL, Farkas W, Garber JE.

Psychooncology. 2008 Aug;17(8):831-43. doi: 10.1002/pon.1279.

23.

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.

Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.

J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12.

PMID:
18270338
24.

Incidence of major corrective surgery after post-mastectomy breast reconstruction and radiation therapy.

Wong JS, Ho AY, Kaelin CM, Bishop KL, Silver B, Gelman R, Harris JR, Hergrueter CA.

Breast J. 2008 Jan-Feb;14(1):49-54. doi: 10.1111/j.1524-4741.2007.00522.x.

PMID:
18186865
25.

A -defensin mutation causes black coat color in domestic dogs.

Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, Nix MA, Kerns JA, Schmutz SM, Millhauser GL, Barsh GS.

Science. 2007 Nov 30;318(5855):1418-23. Epub 2007 Oct 18.

26.

Mammalian comparative sequence analysis of the Agrp locus.

Kaelin CB, Cooper GM, Sidow A, Barsh GS.

PLoS One. 2007 Aug 8;2(8):e702.

27.

Randomized clinical trial: group counseling based on tinnitus retraining therapy.

Henry JA, Loovis C, Montero M, Kaelin C, Anselmi KA, Coombs R, Hensley J, James KE.

J Rehabil Res Dev. 2007;44(1):21-32.

28.

Cancer and Staying fit.

Kaelin CM, Coltrera F.

Newsweek. 2007 Mar 26;149(13):69-70. No abstract available.

PMID:
19130831
29.

Clinical trial to compare tinnitus masking and tinnitus retraining therapy.

Henry JA, Schechter MA, Zaugg TL, Griest S, Jastreboff PJ, Vernon JA, Kaelin C, Meikle MB, Lyons KS, Stewart BJ.

Acta Otolaryngol Suppl. 2006 Dec;(556):64-9.

PMID:
17114146
31.

Sexual problems in younger women after breast cancer surgery.

Burwell SR, Case LD, Kaelin C, Avis NE.

J Clin Oncol. 2006 Jun 20;24(18):2815-21.

PMID:
16782919
32.

Signal transducer and activator of transcription (stat) binding sites but not stat3 are required for fasting-induced transcription of agouti-related protein messenger ribonucleic acid.

Kaelin CB, Gong L, Xu AW, Yao F, Hockman K, Morton GJ, Schwartz MW, Barsh GS, MacKenzie RG.

Mol Endocrinol. 2006 Oct;20(10):2591-602. Epub 2006 May 18.

PMID:
16709597
33.

Outcomes of clinical trial: tinnitus masking versus tinnitus retraining therapy.

Henry JA, Schechter MA, Zaugg TL, Griest S, Jastreboff PJ, Vernon JA, Kaelin C, Meikle MB, Lyons KS, Stewart BJ.

J Am Acad Audiol. 2006 Feb;17(2):104-32.

PMID:
16640064
34.

Clinical management of tinnitus using a "progressive intervention" approach.

Henry JA, Schechter MA, Loovis CL, Zaugg TL, Kaelin C, Montero M.

J Rehabil Res Dev. 2005 Jul-Aug;42(4 Suppl 2):95-116. Review.

35.

Prospective study of wide excision alone for ductal carcinoma in situ of the breast.

Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL.

J Clin Oncol. 2006 Mar 1;24(7):1031-6. Epub 2006 Feb 6.

PMID:
16461781
36.

Effects of hypothalamic neurodegeneration on energy balance.

Xu AW, Kaelin CB, Morton GJ, Ogimoto K, Stanhope K, Graham J, Baskin DG, Havel P, Schwartz MW, Barsh GS.

PLoS Biol. 2005 Dec;3(12):e415. Epub 2005 Nov 29.

37.

When a breast cancer expert gets breast cancer. An interview with Harvard breast cancer surgeon Dr. Carolyn Kaelin.

Kaelin C.

Harv Womens Health Watch. 2005 Apr;12(8):4-6. No abstract available.

PMID:
15844247
38.

PI3K integrates the action of insulin and leptin on hypothalamic neurons.

Xu AW, Kaelin CB, Takeda K, Akira S, Schwartz MW, Barsh GS.

J Clin Invest. 2005 Apr;115(4):951-8. Epub 2005 Mar 10.

39.

Transcriptional regulation of agouti-related protein (Agrp) in transgenic mice.

Kaelin CB, Xu AW, Lu XY, Barsh GS.

Endocrinology. 2004 Dec;145(12):5798-806. Epub 2004 Sep 2.

PMID:
15345681
40.

Ductal carcinoma in situ of the breast.

Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM.

N Engl J Med. 2004 Apr 1;350(14):1430-41. Review. No abstract available.

PMID:
15070793
41.

Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.

Burstein HJ, Harris LN, Gelman R, Lester SC, Nunes RA, Kaelin CM, Parker LM, Ellisen LW, Kuter I, Gadd MA, Christian RL, Kennedy PR, Borges VF, Bunnell CA, Younger J, Smith BL, Winer EP.

J Clin Oncol. 2003 Jan 1;21(1):46-53.

PMID:
12506169
42.

Feasibility of MR imaging-guided breast lumpectomy for malignant tumors in a 0.5-T open-configuration MR imaging system.

Hirose M, Kacher DF, Smith DN, Kaelin CM, Jolesz FA.

Acad Radiol. 2002 Aug;9(8):933-41.

PMID:
12186443
43.

HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.

Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801. Epub 2001 Jul 31.

44.

A SAGE (serial analysis of gene expression) view of breast tumor progression.

Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K.

Cancer Res. 2001 Aug 1;61(15):5697-702.

45.

Sonographic Evaluation of Clinically Palpable Breast Cancers Invisible on Mammography.

Durfee SM, Selland DL, Smith DN, Lester SC, Kaelin CM, Meyer JE.

Breast J. 2000 Jul;6(4):247-251.

PMID:
11348373
46.

Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.

Zhao Y, Verselis SJ, Klar N, Sadowsky NL, Kaelin CM, Smith B, Foretova L, Li FP.

J Clin Oncol. 2001 Mar 1;19(5):1462-7.

PMID:
11230492
47.

Case report: galactography-guided wire localization of an intraductal papilloma.

Chow JS, Smith DN, Kaelin CM, Meyer JE.

Clin Radiol. 2001 Jan;56(1):72-3.

PMID:
11162702
48.

Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.

Seth P, Lunetta KL, Bell DW, Gray H, Nasser SM, Rhei E, Kaelin CM, Iglehart DJ, Marks JR, Garber JE, Haber DA, Polyak K.

Cancer Res. 2000 Dec 15;60(24):6859-63.

49.

The utility of ultrasonographically guided large-core needle biopsy: results from 500 consecutive breast biopsies.

Smith DN, Rosenfield Darling ML, Meyer JE, Denison CM, Rose DI, Lester S, Richardson A, Kaelin CM, Rhei E, Christian RL.

J Ultrasound Med. 2001 Jan;20(1):43-9.

PMID:
11149527
50.

Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision.

Darling ML, Smith DN, Lester SC, Kaelin C, Selland DL, Denison CM, DiPiro PJ, Rose DI, Rhei E, Meyer JE.

AJR Am J Roentgenol. 2000 Nov;175(5):1341-6.

PMID:
11044038

Supplemental Content

Loading ...
Support Center